The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
Open accessAbstract
Individuals with hemizygous germline fumarate hydratase (FH) mutations are predisposed to renal cancer. These tumors predominantly exhibit functional inactivation of the remaining wild-type allele, implicating FH inactivation as a tumor-promoting event. Hypoxia-inducible factors are expressed in many cancers and are increased in clear cell renal carcinomas. Under normoxia, the HIFs are labile due to VHL-dependent proteasomal degradation, but stabilization occurs under hypoxia due to inactivation of HIF prolyl hydroxylase (HPH), which prevents HIF hydroxylation and VHL recognition. We demonstrate that FH inhibition, together with elevated intracellular fumarate, coincides with HIF upregulation. Further, we show that fumarate acts as a competitive inhibitor of HPH. These data delineate a novel fumarate-dependent pathway for regulating HPH activity and HIF protein levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to requiring 2-oxoglutarate as a cosubstrate, the HIF hydroxylases have been reported to be inhibited by citrate, isocitrate, succinate, fumarate, malate, oxaloacetate, and pyruvate (Dalgard et al., 2004; Hewitson et al., 2007; Isaacs et al., 2005; Koivunen et al., 2007a; Selak et al., 2005).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Isaacs et al., 2005
In the citing paper
“To date, the clearest evidence that metabolites modulate HIF signaling comes from cells that are genetically defective in fumarate hydratase (FH) (Isaacs et al., 2005) or succinate hydrogenase (SDH; subunits b, c, and d) (MacKenzie et al., 2007; Pollard et al., 2005; Selak et al., 2005).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Isaacs et al., 2005
In the citing paper
“Similar to succinate, fumarate contributes to the inactivation of PHD, stabilizing HIF proteins to promote cell survival133”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [133]
In the citing paper
“For example, the HIF1α transcription factor accumulates in SDH and FH mutant tumors, presumably due to inhibition of the EglN prolyl hydroxylases (Dahia et al., 2005; Isaacs et al., 2005; Pollard et al., 2005, 2007; Selak et al., 2005).”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Isaacs et al., 2005
In the citing paper
“A similar model of substrate-mediated PHD inhibition has been described (23, 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [23]
In the citing paper
“PHDs are inactive at low O2 and can be inactivated by the accumulation of TCA metabolites fumarate and succinate, which may occur from mutations in the tumor suppressor genes succinate dehydrogenase subunit B or fumarate hydratase (187, 334, 384).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [187]
In the citing paper
“In addition to affecting the activity of chromatin-associated αKG-dependent dioxygenases, succinate and fumarate accumulation can also inhibit αKG-dependent prolyl hydroxylases, leading to stabilization of HIF-1 and concomitant activation of the HIF/hypoxia transcriptional program (184, 185).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [184]
In the citing paper
“High levels of succinate and fumarate can inhibit PHD2 activity through product-mediated inhibition of PHD function, leading to HIF-1α protein stabilization under normoxic (20% O2) conditions (100, 101).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [100]
In the citing paper
“Subsequent work confirmed that fumarate could inhibit PHD2 (Isaacs et al., 2005)”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Isaacs et al., 2005
In the citing paper
“elevated levels of succinate or fumarate can inhibit PHD activity [65, 66]”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [65]
In the citing paper
“Both succinate and fumarate are competitive PHD inhibitors, and the massive accumulation of these metabolites in cells lacking SDH or FH activity elicit a hypoxic response even under oxygen-replete condition (Isaacs et al., 2005; Selak et al., 2005).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Isaacs et al., 2005
In the citing paper
“Furthermore, both succinate and fumarate aberrantly increase the function of hypoxia inducible factors (HIFs).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Isaacs et al., 2005
In the citing paper
“In the case of D2HGA, about 50% of patients present with D2HGDH mutations, while the remaining half possess mutations in the Krebs cycle enzyme isocitrate dehydrogenase 2 (IDH2), which converts isocitrate to α-KG110.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [110]
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
(1999) · PubMed · Cited by 2,204
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 3×
“Succinate also upregulates HIF by inhibiting its proline hydroxylation (Selak et al., 2005), but in vitro enzyme kinetic analysis proves it to be a weaker antagonist of 2-OG, a finding in keeping with its reduced potency (relative to fumarate) in causing intracellular HIF accumulation in A549 cells.”
BackgroundInfluential
Cited by
Sorted by citations
Items 801–900 of 957
Rubrecht, A., Aldrink, J. H., Warren, P. S., Mathew, M. T., Tsuchiya, K. D., Moulas, N., Prasad, V. K., & Shah, N. (2025) · Diagnostic Pathology · doi:10.1186/s13000-025-01706-2 · Cited by 1
Chlamydia trachomatis disrupts host metabolism in primary cervical epithelial cells
Cheong, H. C., Rommel, M. I., Cheok, Y. Y., Chan, Y. T., Tang, T. F., Sulaiman, S., Looi, C. Y., Arulanandam, B. P., Chang, L., & Wong, W. F. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04584-4 · Cited by 1
The Crystallography of Enzymes: A Retrospective and Beyond
Huang, T., Khan, J., Lakhani, S., Li, A., Vyas, A., Hunt, J., Garcia, S. A. E., & Liang, B. (2025) · Crystals · doi:10.3390/cryst15110966 · Cited by 1
Role of Succinate Dehydrogenase in Age‐Related Th17 Inflammation
Ocegueda, E., Chase, G., Niceforo, M., Javidan, A., Gugliuzza, L., Yu, J., Kang, R. Y., Lankowski, A., Stefanik, O., Leclerc, K., et al. (2026) · Aging Cell · doi:10.1111/acel.70451 · Cited by 1
Zhang, W., Zhang, Y., Wang, X., Chen, Y., Li, Y., & Sun, Y. (2026) · Antioxidants · doi:10.3390/antiox15070845 · Cited by 1
Mitochondrial Energy Metabolism in Cancer, Immunoregulation and Antitumour Response
Patrício, J. S., Mendes, C., & Gameiro, P. A. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_17 · Cited by 1
Metabolic danger signals: TCA cycle metabolites regulate immunity and disease
Ryan, T. A. J., & Zanoni, I. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.07.004 · Cited by 1
Reciprocal Crosstalk Between Angiogenesis and Metabolism
Laurent, G., & Mechta‐Grigoriou, F. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_10 · Cited by 1
Síndromes de cáncer renal familiares y hereditarios
Coleman, J. (2008) · Clínicas urológicas de Norteamérica · Cited by 1
THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN AND KIDNEY CANCER
Kaelin, W. G., & Ma, B. (2007) · Medicina-buenos Aires · Cited by 1
Annala, M., Nappi, L., Azad, A., Mo, F., Fazli, L., Chi, K. N., & Wyatt, A. W. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.05.019 · Cited by 1
Fundamentals of cell metabolism and cancer
Devendran, R., Ramesh, V., & Gnanasekaran, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99883-3.00001-9 · Cited by 1
Stine, Z. E., & Dang, C. V. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_57 · Cited by 1
The emerging genetic landscape of renal cell carcinoma
Lee, G., Shinder, B. M., Sadimin, E. T., Stephenson, R. D., & Singer, E. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822824-1.00035-3 · Cited by 1
Chattopadhyay, M., Chanda, A., & Pal, B. (2024) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-66421-2_12 · Cited by 1
Molekular definierte Nierenzellkarzinome 2025
Stöhr, C., Fiegl, A., Bercebal, C., Agaimy, A., & Hartmann, A. (2025) · Die Pathologie · doi:10.1007/s00292-024-01408-4 · Cited by 1
Regulation of cytokine secretion by immunometabolites
Hooftman, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15447-8.00009-x · Cited by 2
Familial Renal Cell Cancers and Pheochromocytomas
Chan–Smutko, G., & Iliopoulos, O. (2010) · Springer eBooks · doi:10.1007/978-0-387-93846-2_9 · Cited by 1
Hereditary Kidney Cancer Syndromes
Pan, S., & Shuch, B. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_8 · Cited by 1
Stewart, E. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00025-5 · Cited by 1
Dow, E., & Winship, I. (2018) · Familial Cancer · doi:10.1007/s10689-018-0081-7 · Cited by 1
Singla, N. (2023) · Kidney Cancer Journal · doi:10.52733/kcj21n4-commentary · Cited by 1
Hypoxic Response and Associated Diseases
Flashman, E., Loenarz, C., & Schofield, C. J. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb232 · Cited by 1
DEFECTS IN TRICARBOXYLIC ACID CYCLE ENZYMES FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN CANCER
Ylisaukko‐oja, S. K. (2007) · Työväentutkimus Vuosikirja · Cited by 1
Cellular Responses to Lactic Acidosis in Human Cancers
Chen, J. L.-Y. (2010) · DukeSpace (Duke University) · Cited by 1
Dhanani, N. N., Vocke, C. D., Bratslavsky, G., & Linehan, W. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-149-3_6 · Cited by 1
Self-citationReséndis-Antonio, O., Arellano-Villavicencio, J. E., Vázquez-Jiménez, A., Oropeza-Valdez, J. J., Padrón-Manrique, C., Prado-Garcı́a, H., & Tovar, A. R. (2024) · Research Square · doi:10.21203/rs.3.rs-4864972/v1 · Cited by 1
Papworth, K. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Familial and Hereditary Syndromes
Shuch, B. M., & Pinto, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7236-0_3
MED12: A NOVEL PLAYER IN UTERINE LEIOMYOMAS
Mäkinen, N. (2015) · Työväentutkimus Vuosikirja
Investigation into the molecular mechanisms of inherited renal cancer
Nahorski, M. S. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham)
In Vivo Imaging of Branched Chain Amino Acid Metabolism in Prostate Cancer
Spielman, D. M. (2012) · doi:10.21236/ada581343
Etablierung und Charakterisierung einer Tetracyclin-induzierbaren PHD2-Knockdown-HeLa-Zelllinie
Le-Huu, S. K.-A. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-818
Mutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
Regulators of angiogenesis in diabetes and tumors
Catrina, S. (2005) · Figshare
Genetics, epigenetics and angiogenesis in renal cell carcinoma
Baldewijns, M. M. L. L. (2009) · doi:10.26481/dis.20090626mb
New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma
Tan, T. H., Lees, J., Pranavan, G., & Yip, D. (2012) · InTech eBooks · doi:10.5772/29248
New Systemic Treatment Approaches for Metastatic Renal Cell Carcinoma
Tan, T. H., Vatandoust, S., & Charakidis, M. (2013) · InTech eBooks · doi:10.5772/55280
Hypoxia‐Inducible Factor 1 (HIF‐1) Mediated Adaptive Responses in the Solid Tumor
Golias, T., & Denko, N. C. (2010) · Wiley eBooks · doi:10.1002/9780470669891.ch12
[Molecular biology of renal cancer: bases for genetic directed therapy in advanced disease].
Maroto, P., & Narvaez, E. C. (2013) · PubMed
Kunkle, B. W. (2011) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi11120809
Protein factors and chemical compounds regulating hypoxic or oxidative stress responses
Oguro, A., Kobayashi, Y., & Imaoka, S. (2015) · Personalized Medicine Universe · doi:10.1016/j.pmu.2015.04.004
The renal cell cancer methylome: tumor biology and clinical applications
van Vlodrop, I. J. H. (2012) · doi:10.26481/dis.20120323iv
Understanding Tumour Metabolic Reprogramming with Metabolomics
Stirdivant, S. M., Milburn, M. V., Eckhart, A. D., & Beebe, K. D. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0025297
The role of EBNA binding proteins in cell transformation
Darekar, S. D. (2013) · Figshare
Lago, C. U. (2009) · Texas ScholarWorks (Texas Digital Library)
Genetic Counseling in Renal Masses
López‐Guerrero, J. A., García‐Casado, Z., Fernández‐Serra, A., & Rubio‐Briones, J. (2008) · Advances in Urology · doi:10.1155/2008/720840
Déficit en fumarate hydratase, létalité synthétique et métabolisme tumoral
Hadoux, J. (2012) · ONCOLOGIE · doi:10.1007/s10269-012-2150-4
Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma
Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11
Biología molecular de los tumores corticales renales
Klatte, T., & Pantuck, A. J. (2008) · Clínicas urológicas de Norteamérica
Characterising the tumour suppression function of folliculin
Preston, R. S. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Dhanani, N. N., Vocke, C. D., Bratslavsky, G., & Linehan, W. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-332-5_2
Self-citationGenetic Counseling for Inherited Forms of Kidney Cancer
Hulick, P. J., Chan–Smutko, G., Zimmer, M., & Iliopoulos, O. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_15
Genetic architecture of renal cell carcinoma: Do we have to know?
Öztürk, H. (2015) · World Journal of Urology · doi:10.1007/s00345-015-1697-y
factor-2 in clear cell renal carcinoma
Kong, H., Lee, S., Beebe, K. E., Scroggins, B. T., Gupta, G. N., Jung, Y., Trepel, J. B., & Neckers, L. Μ. (2010)
Self-citationReviewArticle Genetic Counseling in Renal Masses
Antônio, L. (2008)
An explorative study using next generation sequencing of papillary renal cell carcinoma, type 2
Kim, J., Lee, J., Cha, S., Lee, S., & Kim, J. (2015)
Self-citationHypoxia and Angiogenesis in Glioblastomas
Acker, T., & Plate, K. H. (2007) · Springer eBooks · doi:10.1007/978-3-540-33177-3_11
Cancer of the Kidney and Urogenital Tract
Maher, E. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00070-7
Subcellular localization of hypoxia-inducible factors and HIF regulatory hydroxylases in rat liver.
Khan, Z. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Genetic and molecular background of pheochromocytoma and paraganglioma
Stenman, A. (2015) · Figshare
Carcinomes à cellules rénales: de la pathologie aux voies moléculaires de la carcinogenèse
Perrin, C., Edeline, J., Vigneau, C. M., Patard, J., & Rioux-Leclercq, N. C. (2009) · ONCOLOGIE · doi:10.1007/s10269-009-1064-y
Familial Forms of Renal Cell Carcinoma and Associated Syndromes
Guo, C. C., Smith, A. K., & Pavlovich, C. P. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3286-3_6
FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN NEOPLASIA
Vanharanta, S. (2006) · Työväentutkimus Vuosikirja
Molecular stratification and characterization of clear cell renal cell carcinoma
Brannon, A. R. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0vg5-sc43
The role of mediator complex subunit 12 (MED12) in the murine reproductive tract
Mittal, P. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · doi:10.13140/rg.2.2.20308.60809
Angiogenèse et cancer du rein: hypoxie et pseudo-hypoxie
Germain, S. (2011)
Cutaneous Hamartoneoplastic Disorders
Nathanson, K. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00178-6
Metabolômica da resistência ao metotrexato na leucemia linfóide aguda
Canevarolo, R. R. (2012) · doi:10.47749/t/unicamp.2012.842040
The Role of Mediator Complex Subunit 12 in Leiomyoma Biology
Mittal, P., Wang, X., & Rajkovic, A. (2016) · Current Genetic Medicine Reports · doi:10.1007/s40142-016-0106-1
The Emerging Genetic Landscape in Renal Cell Carcinoma
Willoughby, K., & Drabkin, H. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800886-7.00029-7
Opportunity for Disease-Specific Approaches to Therapy
Pfaffenroth, E. C., & Linehan, W. M. (2009)
Self-citationRegulation of Cellular Oxygen Sensing Pathways by VHL
Heir, P. (2015) · TSpace (University of Toronto)
Mechanisms of communication from mitochondria to lysosomes
Fernández-Mosquera, L. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6214
ИЗМЕНЕНИЯ УРОВНЕЙ ЭКСПРЕССИИ ГЕНОВ МЕТАБОЛИЧЕСКИХ ПУТЕЙ ПРИ СВЕТЛОКЛЕТОЧНОМ РАКЕ ПОЧКИ
Bashmakov, V. Y., Gorbacheva, T., Panevina, A. V., Solodskikh, S. A., Moshurov, I. P., Михайлов, А. М., Маслов, А., & Popov, V. N. (2017) · Доклады Академии наук · doi:10.7868/s0869565217130229
Bashmakov, V. Y., Gorbacheva, T., Panevina, A. V., Solodskikh, S. A., Moshurov, I. P., Mikhaylov, A. A., Maslov, A. Y., & Popov, V. N. (2017) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672917030024
Molecular Basics on Genitourinary Malignancies
Cheng, T. H. T., Lam, W., & Teoh, J. Y. (2019) · Springer eBooks · doi:10.1007/978-3-319-42623-5_45
Mitochondria Remodeling in Cancer
Dornfeld, K. J., & Skildum, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_9
Tamura, T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/281253
HIF-Regulated Leukemogenesis Through the Advances on Epigenetic Mechanism
Dong, L., & Zhu, Y. T. (2018) · InTech eBooks · doi:10.5772/intechopen.75769
Impact of hypoxia on hepatitis B virus replication
Frampton, N. R. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Yamakura, M. U. F. (2012)
Type 2B von Hippel-Lindau disease: molecular biology, tumor growth, and development
Lee, C. M. (2009) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/29tv-bb60
Metabolite-Sensing and Human Diseases
Zhao, S., & Zhao, J. (2016) · Scientia Sinica Vitae · doi:10.1360/n052016-00133
Molecular Pathology of Kidney Tumors
Erdoğan, Ş., Özcan, A., & Truong, L. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-28333-9_18
Ancillary Studies Applied to Renal Masses
Guido, L. P., Hanly, F., Escobedo, B., Pinto, A., & Jordà, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-36036-8_12
Variant Renal Cell Carcinoma Histologies: Therapeutic Considerations
Geynisman, D. M., & Stadler, W. M. (2011) · Springer eBooks · doi:10.1007/978-3-642-21858-3_17
Venkatasubramanian, H., Selvaraj, V., Sudan, R. J. J., Chinnappan, S., Bhuvan, A., & Santhakumar, K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1824812
Mitochondrial metabolism and carcinogenesis
Aras, S., Purandare, N., & Grossman, L. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00001-4
Oxidative Stress and Hypoxia in Cancer: Implications for Radiation Therapy
Roy, A., Tubin, S., Dwarakanath, B. S. R., & Gupta, S. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_136-1
Familial Syndromes and Genetic Causes of Paraganglioma and Phaeochromocytoma
Maher, E. R., & Casey, R. T. (2022) · doi:10.1093/med/9780198870197.003.0119
Variant Renal Carcinoma Histologies: Therapeutic Considerations
Geynisman, D. M., & Stadler, W. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_21
Molecular Basics on Genitourinary Malignancies
Cheng, T. H. T., Lam, W., & Teoh, J. Y. (2018) · Springer eBooks · doi:10.1007/978-3-319-42603-7_45-1
Strobl, J., Mischinger, J., Golbeck, S. V., Pichler, M., & Zigeuner, R. E. (2022) · Springer Reference Medizin · doi:10.1007/978-3-642-41168-7_63-2
Brökers, N. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1092
Zigeuner, R. E., Golbeck, S. V., & Pichler, M. (2016) · Springer eBooks · doi:10.1007/978-3-642-39940-4_63
Metadata
- Authors
- Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., Ratcliffe, P. J., Linehan, W. M., & Neckers, L.
- Affiliations
- National Institutes of Health (US)
- Pusan National University (KR)
- University of Oxford (GB)
- National Cancer Institute (US)
- St George's Hospital (GB)
- Corresponding author
- Neckers, Len
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 8
- Issue
- 2
- Pages
- 143-153
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2059747280
- Semantic Scholar
- 6906ef0c1fe45571640c3c7a6b3c9c2d9a979a64
- Cited by
- 958
- References
- 63
- Citations by year
- 2026: 26 · 2025: 30 · 2024: 30 · 2023: 36 · 2022: 45 · 2021: 37 · 2020: 46 · 2019: 40 · 2018: 50 · 2017: 40 · 2016: 44 · 2015: 64 · 2014: 54 · 2013: 60 · 2012: 64
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- fumarate hydratase, hypoxia-inducible factor, fumarate, HIF prolyl hydroxylase, competitive inhibition, clear cell renal cell carcinoma, biallelic loss, cancer susceptibility, hypoxia
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Adult, Alleles, Carcinoma, Renal Cell, DNA-Binding Proteins, Female, Fumarate Hydratase, Fumarates, Humans, Ketoglutaric Acids, Kidney Neoplasms, Male, Middle Aged, Nuclear Proteins, Procollagen-Proline Dioxygenase, Syndrome, Transcription Factors, Up-Regulation, Gene Expression Regulation, Neoplastic, Leiomyomatosis, Basic Helix-Loop-Helix Proteins, Basic Helix-Loop-Helix Transcription Factors, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
